SCHEMBL4667328

SCHEMBL4667328

N#Cc1ccccc1CCNC(=O)c1c(O)c(-c2ccccc2)nc2ccccc12

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.53
DHODH Q02127 4/20 0.52
PDE10A Q9Y233 1/20 0.52
TACR3 P29371 8/20 0.50
TACR2 P21452 2/20 0.50
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2D6 P10635 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
TACR1 P25103 1/20 0.50
OPRM1 P35372 1/20 0.50
TP53 P04637 1/20 0.43
HIF1A Q16665 1/20 0.42
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4668727 0.89 LMNA (0.53) LMNATACR3TACR2CYP1A2CYP3A4
SCHEMBL4665580 0.88 LMNA (0.55) LMNADHODHPDE10ATACR3TACR2
SCHEMBL4665602 0.88 LMNA (0.57) LMNADHODHPDE10ATACR3TACR2
SCHEMBL4667842 0.86 TACR3 (0.56) LMNATACR3TACR2CYP3A4ALDH1A1
SCHEMBL5045776 0.86 CYP2D6 (0.56) LMNADHODHPDE10ATACR3TACR2
SCHEMBL5041963 0.85 TACR3 (0.55) LMNAPDE10ATACR3TACR2CYP1A2
SCHEMBL5045996 0.85 LMNA (0.57) LMNAPDE10ATACR3TACR2CYP1A2
SCHEMBL5042633 0.84 LMNA (0.56) LMNADHODHTACR3TACR2CYP1A2
SCHEMBL5045721 0.84 LMNA (0.51) LMNAPDE10ATACR3TACR2CYP1A2
SCHEMBL5042219 0.83 LMNA (0.55) LMNATACR3TACR2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928834-A1 ALKYLNITRILE QUINOLINES, AS NK-3 RECEPTOR LIGANDS AstraZeneca AB (SE) 2008-06-11 EP claimed
WO-2007035157-A1 ALKYLNITRILE QUINOLINES, AS NK-3 RECEPTOR LIGANDS ASTRAZENECA AB (SE) 2007-03-29 WO claimed
EP-1928834-A1 ALKYLNITRILE QUINOLINES, AS NK-3 RECEPTOR LIGANDS AstraZeneca AB (SE) 2008-06-11 EP disclosed
WO-2007035157-A1 ALKYLNITRILE QUINOLINES, AS NK-3 RECEPTOR LIGANDS ASTRAZENECA AB (SE) 2007-03-29 WO disclosed